Research Article
MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma
Table 1
Correlation between MRGBP expression and clinicopathological characteristics of patients with HNSC.
| Characteristic | Low expression of MRGBP | High expression of MRGBP | |
| | 251 | 251 | | Age, (%) | | | 0.502 | ≤60 | 118 (23.6%) | 127 (25.3%) | | >60 | 132 (26.3%) | 124 (24.8%) | | Gender, (%) | | | 0.003 | Female | 82 (16.3%) | 52 (10.4%) | | Male | 169 (33.7%) | 199 (39.6%) | | Race, (%) | | | 0.310 | Asian | 6 (1.2%) | 4 (0.8%) | | Black or African American | 19 (3.9%) | 28 (5.8%) | | White | 218 (44.9%) | 210 (43.3%) | | Smoker, (%) | | | 0.026 | No | 67 (13.6%) | 44 (8.9%) | | Yes | 182 (37%) | 199 (40.4%) | | Clinical stage, (%) | | | 0.569 | Stage I | 12 (2.5%) | 7 (1.4%) | | Stage II | 51 (10.5%) | 44 (9%) | | Stage III | 49 (10%) | 53 (10.9%) | | Stage IV | 134 (27.5%) | 138 (28.3%) | | T stage, (%) | | | 0.069 | T1 | 19 (3.9%) | 14 (2.9%) | | T2 | 82 (16.8%) | 62 (12.7%) | | T3 | 67 (13.8%) | 64 (13.1%) | | T4 | 77 (15.8%) | 102 (20.9%) | | N stage, (%) | | | 0.124 | N0 | 127 (26.5%) | 112 (23.3%) | | N1 | 35 (7.3%) | 45 (9.4%) | | N2 | 77 (16%) | 77 (16%) | | N3 | 1 (0.2%) | 6 (1.2%) | | M stage, (%) | | | 0.373 | M0 | 237 (49.7%) | 235 (49.3%) | | M1 | 4 (0.8%) | 1 (0.2%) | | Age, median (IQR) | 61 (54, 69) | 60 (52.5, 67) | 0.174 |
|
|